Teriparatide Acetate (hpth (1-34)) Powder
Product Images NDC 52416-126

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Teriparatide Acetate (hpth (1-34)) (NDC 52416-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bachem Americas, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Teriparatide Acetate (hpth (1-34)) (Hpth)

Packaging label for Teriparatide Acetate (hPTH (1-34)) bulk ingredient powder, strength 1 g/g, by Bachem Americas, Inc. The label includes molecular weight 4117.77, storage instructions at -20 ± 2 °C, manufacturing date March 2019, retest date March 2020, and NDC 052416-126-01. Hazard warnings and handling precautions are also present, with the labeler's address in Torrance, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.